Loading clinical trials...
Loading clinical trials...
BLEXI: A Study of BLEpharospasm Management With daXIbotulinumtoxinA
Conditions
Interventions
Botulinum Neurotoxin Type A
Locations
1
United States
Parkinson Disease and Movement Disorders Center at the University of Pennsylvania
Philadelphia, Pennsylvania, United States
Start Date
July 1, 2026
Primary Completion Date
June 30, 2028
Completion Date
December 31, 2028
Last Updated
March 24, 2026
Lead Sponsor
University of Pennsylvania
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions